2015
DOI: 10.1186/s12937-015-0056-6
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis

Abstract: Most hepatocellular carcinoma (HCC) patients have complications, including cirrhosis and malnutrition. The efficacy of dietary supplementation with oral branched-chain amino acids (BCAAs) in HCC patients undergoing interventions has not been confirmed. Relevant publications on the efficacy and safety of oral BCAA supplementation for HCC patients undergoing anti-HCC interventions through September, 2014 were searched for identification in the PubMed, Embase, Web of Science, and the Cochrane Library databases. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
31
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(34 citation statements)
references
References 44 publications
0
31
3
Order By: Relevance
“…The administration of branched-chain amino acid effectively maintains the Child-Pugh score during chemotherapy of patients with advanced HCC [20,21]. In contrast, the present study did not detect a significant effect of consumption of branched-chain amino acids on maintaining Child-Pugh scores.…”
Section: Discussioncontrasting
confidence: 53%
“…The administration of branched-chain amino acid effectively maintains the Child-Pugh score during chemotherapy of patients with advanced HCC [20,21]. In contrast, the present study did not detect a significant effect of consumption of branched-chain amino acids on maintaining Child-Pugh scores.…”
Section: Discussioncontrasting
confidence: 53%
“…This is because patients with LC exhibited ascites due to low albumin levels, which can be improved through the supplementation of BCAAs. Our results is inconsistent with the meta‐analysis results reported by Chen et al . The only indicator for liver function that did not show significant differences was Bil‐T.…”
Section: Discussioncontrasting
confidence: 99%
“…Previous studies have proposed the use of BCAA supplementation for the treatment of hepatic encephalopathy (36,44), and others have noted improved nutritional balance and a decreased frequency of cirrhosis-related complications with BCAA supplementation (45)(46)(47). In addition to the nutritional role of BCAAs, studies have also evaluated patient QoL based on SF-36 tests (46,47).…”
Section: Discussionmentioning
confidence: 99%
“…In addition to the nutritional role of BCAAs, studies have also evaluated patient QoL based on SF-36 tests (46,47). However, the effect of BCAA supplementation on IR and its association with viral load is less understood (29,30).…”
Section: Discussionmentioning
confidence: 99%